CITrials COVID-19 Update

We at CiTrials are continually up to date with our local, state, and federal health guidelines so that our daily activities including but not limited to volunteer visits, on-site services, study medications, supplies, and labs are not impacted.
As more of our counties open, more clinical studies are also open for participation. Our volunteers’ safety is our number priority as they enroll into studies. Our health care staff continue to follow strict safety requirements including checking body temperature, wearing of masks and social distancing for all our volunteers at our clinics in Bellflower, Santa Ana and Riverside. 
We want to thank our volunteers for dedicating their time to help the medical community advance medical research for the benefit of our fellow citizens. And a huge thank you to all the health care workers for keeping everyone safe. Mask On. Live On

New Medication Approved For Alzheimer’s Disease

CITrials COVID-19 Update

CITrials has contingency measures implemented to manage conducting clinical trials during COVID-19 – our teams + rate is currently 0%.

We will be open from 8:30 am to 7:00 pm, Monday through Sunday so that our volunteers can come into office with less stress and less total people!

New Medication Approved For Alzheimer’s Disease

New Medication Approved For Alzheimer’s Disease

Belsroma, a new drug for Alzheimer’s induced insomnia, has been approved by the FDA thanks to the research done by CITrials. This new medication can help patients that suffer from mild-to-moderate Alzheimers. With the help of Belsroma, said patients can experience less disruption during sleep. This 4-week study had 285 participants, with significant improvement in Sleep Time (TST) and wake after sleep onset (WASO) measures compared to a placebo group.

http://www.sbwire.com/press-releases/citrials-clinical-work-helps-merck-wins-alzheimers-label-claim-for-insomnia-drug-belsomra-1279356.htm